Diana Trang赞助的临床试验
总计1599个结果
-
Dana-Farber Cancer InstituteGilead Sciences终止
-
Singapore General HospitalDiana Chan Xin Hui; Lin Xufeng; Yap Haoyun招聘中
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, Australia完全的Transitional Cell Carcinoma of Urinary Bladder澳大利亚, 新西兰
-
Dana-Farber Cancer InstituteBayer; AbbVie主动,不招人
-
Dana-Farber Cancer InstitutePrometheus Laboratories主动,不招人
-
Dana-Farber Cancer InstituteRegeneron Pharmaceuticals主动,不招人
-
Dana-Farber Cancer InstituteGilead Sciences主动,不招人
-
Dana-Farber Cancer InstituteMedivation, Inc.完全的
-
AEterna ZentarisDana-Farber Cancer Institute终止
-
Dana-Farber Cancer InstituteCelgene Corporation终止头颈部鳞状细胞癌 | 基底样鳞状细胞癌 | 未分化癌 | 腺鳞癌
-
Dana-Farber Cancer InstituteBayer; Novartis完全的
-
State Key Laboratory of Cancer BiologyXijing Hospital; Tang-Du Hospital未知
-
State Key Laboratory of Cancer BiologyXijing Hospital; Tang-Du Hospital未知
-
Dana-Farber Cancer InstituteSiemens Medical Solutions招聘中
-
Dana-Farber Cancer InstituteNH TherAguix SAS招聘中
-
Dana-Farber Cancer InstituteAstraZeneca; Osteosarcoma Institute招聘中
-
Dana-Farber Cancer InstituteSecura Bio, Inc.招聘中
-
Dana-Farber Cancer InstituteBristol-Myers Squibb终止
-
Dana-Farber Cancer InstituteNanoString Technologies, Inc.主动,不招人
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.终止
-
Dana-Farber Cancer InstituteBristol-Myers Squibb主动,不招人
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.终止
-
Dana-Farber Cancer InstituteMyriad Genetics, Inc.主动,不招人
-
Dana-Farber Cancer InstituteSecura Bio, Inc.主动,不招人
-
Dana-Farber Cancer InstituteOncology Nursing Society完全的
-
Dana-Farber Cancer InstituteGenentech, Inc.; Exelixis完全的
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.完全的
-
Dana-Farber Cancer InstituteBristol-Myers Squibb撤销